ArticleJournal of pharmacy & bioallied sciences2024
Probing the Clinical, Laboratory, and Sociodemographic Factors Associated with Malaria: A Case-Control Study.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The National Malaria Elimination Program (NMEP) has helped reduce the mortality from malaria in India, and there are alarmingly high mortality rates from anemia in certain geographical regions. Aim: To assess the clinical, laboratory, and sociodemographic factors associated with malaria from P. falciparum and P. vivax. Methods: This retrospective record-based clinical study subjects with malaria were further divided into P. vivax and P. falciparum cases. In all the cases, the clinical, laboratory, and sociodemographic factors were assessed. Data gathered were analyzed statistically. Results: During the study period, 222 cases of malaria were assessed where 22.52% (n = 50) and 74.48% (n = 172) cases were due to P. falciparum and P. vivax, respectively. Hepatomegaly was common in P. falciparum cases and splenomegaly in P. vivax cases. Thrombocytopenia was seen in 58.1% (n = 100) and 72% (n = 36) subjects with P. vivax and P. falciparum cases. No significant difference was seen in other laboratory parameters. Conclusions: Clinical, laboratory, and sociodemographic factors associated with malaria from P. falciparum and P. vivax have no statistically significant difference.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.